Immunization Update 2017

Activity Preview

The 2017 immunization schedules for children and adults include a variety of changes. A new figure has been created for children and adolescents aged 18 years and younger that provides vaccine recommendations based on medical indications. Updates have been made to the vaccine recommendations for influenza, human papillomavirus, meningococcal disease, hepatitis B, and Tdap use in pregnancy.

Learning Objectives

Learning objectives (Pharmacists): 

At the conclusion of this knowledge-based activity, the pharmacist will be able to: 

  1.       Describe the impact that unvaccinated persons have on the economic burden of vaccine-preventable diseases and Healthy People 2020 immunization and infectious disease targets
  2.       Describe the updates to the seasonal influenza vaccine recommendations and vaccines used to treat influenza
  3.       Determine which patients are candidates for the newly-approved two-dose meningococcal B and HPV vaccine schedules
  4.       Summarize the changes in the 2017 immunization schedules for adults and children with regard to Tdap, meningococcal conjugate, and hepatitis B vaccine recommendations
  5.       Provide vaccine recommendations for travelers to areas with a risk for cholera and yellow fever transmission
  6.       Recognize opportunities to reduce vaccine administration errors and the importance of reporting when errors occur

 Learning objectives (Pharmacy Technicians):

 At the conclusion of this knowledge-based activity, the pharmacist will be able to: 

  1.       Describe the impact that unvaccinated persons have on the economic burden of vaccine-preventable diseases and Healthy People 2020 immunization and infectious disease targets
  2.       Describe the updates to the seasonal influenza vaccine recommendations and vaccines used to treat influenza
  3.       Determine which patients are candidates for the newly-approved two-dose meningococcal B and HPV vaccine schedules
  4.       Summarize the changes in the 2017 immunization schedules for adults and children with regard to Tdap, meningococcal conjugate, and hepatitis B vaccine recommendations
  5.       Recognize opportunities to reduce vaccine administration errors and the importance of reporting when errors occur

Activity type: Knowledge-based
Target Audience
: Pharmacists &  Pharmacy Technicians
Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Numbers for this activity is 0202-0000-17-159-H01-P/T.

To obtain credit for "Immunization Update 2017" complete the assessment with a grade of 70% or better, evaluation questions, and CLAIM credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: May 1, 2017
Expiration date: May 1, 2020 - NO CREDIT GRANTED AFTER THIS DATE

Development

"Immunization Update 2017” is a home-study continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.

Advisory Board

Stephan L. Foster, PharmD, FAPhA

CAPT (Ret.), U.S. Public Health Service

Professor (Ret.), University of Tennessee College of Pharmacy, Memphis

Liaison Representative to Advisory Committee on Immunization Practices, CDC

Disclosures

Stephan L. Foster, PharmD, FaPhA, declares that he is on the speakers bureaus for Merck Vaccine, Pfizer, and Seqirus.

Lauren B. Angelo, PharmD, MBA, and APhA's editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.  

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the Technology System Requirements to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-17-159-H01-P 0.2 CEUs May 01, 2017 - May 01, 2020
ACPE# 0202-0000-17-159-H01-T 0.2 CEUs May 01, 2017 - May 01, 2020